Two Sigma Securities’s DataMeds AI MEDS Stock Holding History

Two Sigma Securities’s Portfolio MEDS Stock Details MEDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-557	Closed	-$11.1K	–	2345
2025 Q4	$11.1K	Buy	+557	New	+$16.3K	﹤0.01%	1277

Other funds holding MEDS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Securities's MEDS Position: Q1 2026 in Review

Two Sigma Securities sold out of DataMeds AI (MEDS) in Q1 2026, closing a stake of 557 shares — an estimated $11.1K sold.

Two Sigma Securities first reported a position in MEDS in Q4 2025 and held it in 1 quarter. The position peaked at $11.1K in Q4 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

Two Sigma Securities reported no remaining DataMeds AI position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 557 DataMeds AI shares in Q1 2026, an estimated $11.1K.
Two Sigma Securities first reported a position in DataMeds AI in Q4 2025 and held it in 1 quarter.
Two Sigma Securities's DataMeds AI position peaked at $11.1K in Q4 2025.
13 funds tracked by Wall St. Rank held DataMeds AI as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.